Medtronic PLC Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.Medtronic PLC (MDT) shares fell 1.94% to $92.30 on Thursday, snapping a two-day winning streak amid a broader market decline. Despite the drop, Medtronic outperformed competitors like Johnson & Johnson and Abbott Laboratories. The stock remains 13.19% below its 52-week high of $106.33. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Medtronic PLC (MDT) shed 1.94% to $92.30 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
The stock's fall snapped a two-day winning streak.
Medtronic PLC closed 13.19% below its 52-week high of $106.33, which the company achieved on November 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 2.21% to $267.37, Danaher Corp. (DHR) rose 2.09% to $215.91, and Abbott Laboratories (ABT) fell 0.25% to $114.14.
Trading volume (6.0 M) remained 2.0 million below its 50-day average volume of 8.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-20-26 1638ET